Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:appearance |
colorless, viscous liquid
|
| gptkbp:boilingPoint |
230 °C
|
| gptkbp:CASNumber |
110-63-4
|
| gptkbp:chemicalFormula |
C4H10O2
|
| gptkbp:country_of_regulation |
gptkb:Australia
gptkb:United_Kingdom gptkb:United_States |
| gptkbp:density |
1.017 g/cm³
|
| gptkbp:EC_number |
203-786-5
|
| gptkbp:hasInChIKey |
InChI=1S/C4H10O2/c5-3-1-2-4-6/h5-6H,1-4H2
WQZGKKKJIJFFOK-UHFFFAOYSA-N |
| gptkbp:hasSMILES |
C(CCO)CO
|
| https://www.w3.org/2000/01/rdf-schema#label |
1,4-Butanediol
|
| gptkbp:IUPACName |
butane-1,4-diol
|
| gptkbp:KEGGID |
C01703
|
| gptkbp:meltingPoint |
20.1 °C
|
| gptkbp:metabolism |
gamma-hydroxybutyric acid
|
| gptkbp:molecularWeight |
90.12 g/mol
|
| gptkbp:predecessor |
gptkb:tetrahydrofuran
polybutylene terephthalate gamma-butyrolactone |
| gptkbp:PubChem_CID |
gptkb:CHEMBL418
8064 16962 |
| gptkbp:regulation_status |
controlled substance in some countries
|
| gptkbp:relatedTo |
gptkb:tetrahydrofuran
gamma-hydroxybutyric acid gamma-butyrolactone |
| gptkbp:riskFactor |
toxic if ingested
CNS depressant can be abused as a recreational drug |
| gptkbp:routeOfAdministration |
oral
inhalation intravenous |
| gptkbp:solubility |
miscible
|
| gptkbp:synthesisType |
Davy process
Reppe process hydrogenation of succinic acid |
| gptkbp:UNII |
Q50X9P7VP7
|
| gptkbp:uses |
gptkb:plastic
pharmaceuticals solvent polymer production industrial chemical intermediate precursor to gamma-butyrolactone precursor to tetrahydrofuran |
| gptkbp:bfsParent |
gptkb:GBL
|
| gptkbp:bfsLayer |
7
|